Skip to main
MXCT

MaxCyte (MXCT)


$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy MaxCyte (MXCT) Stock

About MaxCyte (MXCT)

MaxCyte, Inc. engages in the development and licensing of cell-engineering technologies to pharmaceutical and biotechnology companies. Its propriety cell therapy is used in drug discovery and development, and biomanufacturing. Its products include ATx, STx, and GTx instruments. The company was founded by Douglas A. Doerfler on July 31, 1998 and is headquartered in Rockville, MD.
Market cap$116.48M
Today's volume643.51K
Revenue (TTM)$32.29M
Avg. daily volume1.02M
EBITDA (TTM)-$33.34M
Open$1.09
Price / earnings ratio-2.97x
Today's range$1.01 - $1.09
Debt / equity0.1x
52 week range$0.64 - $2.4
5 year debt / equity0.07x
Beta (LTM)1.67x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio12.04x
Ex-dividend date
Next earnings
Dividend payable date

MaxCyte Stock Rating

What analysts recommend for MXCT stock, on a scale from 1(buy) to 5(sell).
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of May 14, 2026, the market cap for MaxCyte stock is $116.48M

The current P/E ratio for MaxCyte stock is -2.97

The 52-week high for MaxCyte stock is $2.40. The current MaxCyte stock price $undefined is 100.00% below its 52-week high

The 52-week low for MaxCyte stock is $0.64. The current MaxCyte stock price $undefined has increased 100.00% from its 52-week low

No, the MaxCyte stock does not pay dividends to its shareholders

The target price for MaxCyte stock is $5.50 based on the average of what a group of analyst think MaxCyte stock could be worth at a future date. This is not a prediction by Public.com

How to buy MaxCyte stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in MaxCyte stock

    Navigate to the Explore page. Then, type MaxCyte into the search bar. When you see MaxCyte stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased MaxCyte stock in your portfolio alongside the rest of your stocks, ETFs, crypto, bonds, options, and your high-yield cash account––all in one place on Public.

MaxCyte Stock Earnings

The value each MXCT share was expected to gain vs. the value that each MXCT share actually gained.

MaxCyte (MXCT) reported Q1 2026 earnings per share (EPS) of -$0.04, beating estimates of -$0.09 by 55.56%. In the same quarter last year, MaxCyte's earnings per share (EPS) was -$0.10. MaxCyte is expected to release next earnings on , with an earnings per share (EPS) estimate of -$0.09.

Buy MaxCyte (MXCT) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.